Edition:
United States

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

1.24USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.24
Open
$1.22
Day's High
$1.24
Day's Low
$1.17
Volume
182,325
Avg. Vol
18,733
52-wk High
$3.45
52-wk Low
$0.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 7.04 -0.134
Mar '18 7.67 -0.165
FY 2017 Dec '17 7.52 0.325
Sep '17 8.03 -0.029
Jun '17 6.60 -0.140
Mar '17 6.97 -0.507
FY 2016 Dec '16 7.23 -0.147
Sep '16 6.75 -0.227
Jun '16 7.00 -0.277
Mar '16 6.07 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 7.57 8.09 7.05 11.73
Quarter Ending Dec-18 2 8.12 9.20 7.05 12.61
Year Ending Dec-18 2 30.40 31.99 28.80 43.45
Year Ending Dec-19 2 50.16 53.51 46.82 50.09
Earnings (per share)
Quarter Ending Sep-18 2 -0.17 -0.16 -0.18 -0.04
Quarter Ending Dec-18 2 -0.16 -0.12 -0.19 -0.01
Year Ending Dec-18 2 -0.62 -0.58 -0.67 -0.17
Year Ending Dec-19 2 -0.22 -0.11 -0.34 -0.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 35.77 32.55
P/E High - Last 5 Yrs. -- 111.04 47.13
P/E Low - Last 5 Yrs. -- 26.09 24.86
Beta 0.57 0.49 0.87
Price to Sales (TTM) 1.14 6.49 6.32
Price to Book (MRQ) 1.99 3.59 3.96
Price to Tangible Book (MRQ) -- 5.55 6.00
Price to Cash Flow (TTM) 46.00 18.39 22.84
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.00 1.68
Dividend Yield - 5 Year Avg -- 0.83 1.45
Dividend 5 Year Growth Rate -- 7.08 -5.90
Payout Ratio(TTM) -- 31.40 46.65

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 6.54 7.20 8.33
Sales (TTM) vs TTM 1 Yr. Ago 9.81 9.15 6.69
Sales - 5 Yr. Growth Rate 46.59 12.53 7.54
EPS (MRQ) vs Qtr. 1 Yr. Ago 4.36 -71.22 25.23
EPS (TTM) vs TTM 1 Yr. Ago 99.67 -- --
EPS - 5 Yr. Growth Rate -- 5.74 7.60
Capital Spending - 5 Yr. Growth Rate 36.48 12.81 8.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.75 2.21
Current Ratio (MRQ) 0.66 3.92 2.98
LT Debt to Equity (MRQ) 3.26 38.57 11.20
Total Debt to Equity (MRQ) 59.75 44.24 14.01
Interest Coverage (TTM) -2.30 29.56 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 34.68 38.78 54.70
Gross Margin - 5 Yr. Avg. 31.17 42.49 53.20
EBITD Margin (TTM) -68.55 -- --
EBITD - 5 Yr. Avg -84.63 12.15 15.84
Operating Margin (TTM) -75.71 9.04 3.87
Operating Margin - 5 Yr. Avg. -92.72 5.89 10.99
Pre-Tax Margin (TTM) -58.61 8.34 4.20
Pre-Tax Margin - 5 Yr. Avg. -101.25 6.97 11.19
Net Profit Margin (TTM) -4.69 5.67 0.91
Net Profit Margin - 5 Yr. Avg. -77.65 4.25 7.51
Effective Tax Rate (TTM) -- 19.39 20.56
Effective Tax Rate - 5 Yr. Avg. -- 28.00 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) 138,780 8,486,480 725,212,627
Net Income/Employee (TTM) -6,505 -215,625 83,818,761
Receivable Turnover (TTM) 2.69 7.34 5.04
Inventory Turnover (TTM) -- 63.22 3.63
Asset Turnover (TTM) 0.74 0.55 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -3.45 5.25 9.83
Return on Assets - 5 Yr. Avg. -31.53 6.83 10.96
Return on Investment (TTM) -5.49 6.68 12.80
Return on Investment - 5 Yr. Avg. -40.49 8.56 14.08
Return on Equity (TTM) -7.90 9.86 14.92
Return on Equity - 5 Yr. Avg. -50.47 12.36 15.41
  1 Year 3 Year 5 Year
Sales % 7.66 41.87 46.59
EPS (TTM) % 72.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cancer Genetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.90%
# of Holders: 27
Total Shares Held: 4,135,510
3 Mo. Net Change: -662,780
# New Positions: 2
# Closed Positions: 8
# Increased Positions: 9
# Reduced Positions: 14
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.